X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1028) 1028
Paper (658) 658
Publication (473) 473
Report (98) 98
Data Set (4) 4
Book Review (3) 3
Book / eBook (1) 1
Conference Proceeding (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
experiment (708) 708
physics (663) 663
particle physics (650) 650
high energy physics - experiment (642) 642
physics - high energy physics - experiment (587) 587
high energy physics (485) 485
cern lhc coll (471) 471
experimental results (463) 463
p p: scattering (361) 361
physics of elementary particles and fields (329) 329
cms (324) 324
p p: colliding beams (316) 316
phenomenology (299) 299
particle physics - experiment (250) 250
13000 gev-cms (246) 246
hep (217) 217
nuclear experiment (195) 195
hadron-hadron scattering (186) 186
physics, particles & fields (184) 184
scattering [p p] (174) 174
[phys.hexp]physics [physics]/high energy physics - experiment [hep-ex] (151) 151
colliding beams [p p] (136) 136
8000 gev-cms (125) 125
background (119) 119
elementary particles, quantum field theory (115) 115
quantum field theories, string theory (115) 115
ex (108) 108
physical sciences (102) 102
astrophysics (93) 93
astronomy & astrophysics (89) 89
classical and quantum gravitation, relativity theory (84) 84
quantum physics (84) 84
[ phys.hexp ] physics [physics]/high energy physics - experiment [hep-ex] (81) 81
fysik (81) 81
natural sciences (81) 81
naturvetenskap (81) 81
supersymmetry (75) 75
high energy astrophysical phenomena (74) 74
cern lab (73) 73
mass dependence (70) 70
collisions (69) 69
channel cross section: upper limit (61) 61
channel cross section: branching ratio: upper limit (60) 60
transverse momentum: missing-energy (59) 59
large hadron collider (58) 58
instrumentation and detectors (57) 57
decay (55) 55
data analysis method (53) 53
final state:jet lepton (53) 53
higgs particle: hadroproduction (53) 53
top: pair production (51) 51
kinematics (50) 50
muon: pair production (50) 50
nuclear physics (50) 50
rapidity dependence (49) 49
114 physical sciences (48) 48
nuclear and high energy physics (48) 48
physics, nuclear (46) 46
bottom: particle identification (45) 45
detectors (45) 45
hep-ex (45) 45
physics, multidisciplinary (45) 45
z0: leptonic decay (45) 45
luminosity (44) 44
transverse momentum dependence (44) 44
jet: bottom (42) 42
quantum chromodynamics: perturbation theory (41) 41
channel cross section: measured (38) 38
index medicus (38) 38
final state:jet dilepton (37) 37
beyond standard model (36) 36
astronomy, astrophysics and cosmology (35) 35
mass spectrum: (35) 35
7000 gev-cms (34) 34
physics and astronomy (34) 34
searching (34) 34
higgs bosons (33) 33
humans (33) 33
jet: multiplicity (33) 33
sensitivity (33) 33
transverse momentum (33) 33
bottom: pair production (31) 31
jet: transverse momentum (31) 31
measurement science and instrumentation (31) 31
nuclear energy (31) 31
nuclear physics, heavy ions, hadrons (31) 31
resonance: production (31) 31
structure (31) 31
jets (30) 30
lead (30) 30
lhc (30) 30
nuclear and particle physics. atomic energy. radioactivity (30) 30
física (29) 29
narrow resonance (29) 29
tau: pair production (29) 29
analysis (28) 28
broken symmetries (28) 28
differential cross section: measured (28) 28
higgs physics (28) 28
model (28) 28
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2013, Volume 382, Issue 9902, pp. 1424 - 1432
Journal Article
Clinical Therapeutics, ISSN 0149-2918, 2012, Volume 34, Issue 8, pp. 1774 - 1787
Abstract Background Chronic graft-versus-host disease (cGvHD) is the leading cause of late nonrelapse mortality (transplant-related mortality) after... 
Internal Medicine | Medical Education | cost-effectiveness | extracorporeal photopheresis | chronic graft | host disease | Host disease | Extracorporeal photopheresis | Cost-effectiveness | Chronic graft | EXTRACORPOREAL PHOTOCHEMOTHERAPY | T-CELL LYMPHOMA | MONOCLONAL-ANTIBODY | TRANSPLANTATION | ECONOMIC-EVALUATION | RITUXIMAB | SALVAGE THERAPY | PHARMACOLOGY & PHARMACY | PHOTOPHERESIS | REFRACTORY CHRONIC GVHD | IMATINIB MESYLATE | Drug Costs | Graft vs Host Disease - therapy | Humans | Immunosuppressive Agents - therapeutic use | Needs Assessment - economics | Photopheresis - economics | Piperazines - economics | Health Services Needs and Demand - economics | Models, Economic | Time Factors | Computer Simulation | Immunosuppressive Agents - economics | Graft vs Host Disease - diagnosis | Graft vs Host Disease - economics | Quality-Adjusted Life Years | Photopheresis - adverse effects | Antibodies, Monoclonal, Murine-Derived - economics | National Health Programs - economics | Rituximab | Treatment Outcome | Piperazines - therapeutic use | Pyrimidines - economics | Imatinib Mesylate | Piperazines - adverse effects | Spain | Health Care Costs | Pyrimidines - therapeutic use | Cost-Benefit Analysis | Pyrimidines - adverse effects | Immunosuppressive Agents - adverse effects | Benzamides | Antibodies, Monoclonal, Murine-Derived - adverse effects | Chronic Disease | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Health Care Rationing - economics | Transplantation | Hematopoietic stem cells | Stem cells | Studies | Transplants & implants | Mortality | Economia de la salut | Espanya | Medical economics
Journal Article
Intensive Care Medicine, ISSN 0342-4642, 9/2018, Volume 44, Issue 9, pp. 1470 - 1482
Journal Article
by Román, Luis San and Menon, BK and Menon, Bijoy K and Blasco, J and Blasco, Jordi and Hernández-Pérez, M and Hernández-Pérez, María and Dávalos, Antoni and Dávalos, A and Majoie, Charles B L M and Majoie, Charles B.L.M and Campbell, D and Campbell, Bruce C V and Campbell, N and Campbell, Bruce CV and Guillemin, Francis and Lingsma, Hester F and Lingsma, Hester and Anxionnat, René and Epstein, Jonathan and Saver, Jeffrey L and Marquering, Henk and Marquering, Henk A and Wong, John H and Wong, JH and Wong, Kitty and Wong, Andrew and Lopes, DK and Lopes, Demetrius and Reimann, G and Reimann, Gernot and Desal, Hubert and Dippel, Diederik W.J and Dippel, Diederik W J and Coutts, SB and Coutts, Shelagh and du Mesnil de Rochemont, R and du Mesnil de Rochemont, Richard and Yavagal, Dileep and Yavagal, D and Yavagal, Dileep R and Ferre, Jean Christophe and Ferre, Jean-Christophe and Roos, Yvo B.W.E.M and Roos, Yvo B W E M and Liebeskind, D and Liebeskind, David S and Lenthall, Robert and Lenthall, Rob and Molina, Carlos and Molina, CA and Al Ajlan, Fahad S and Reddy, R and Reddy, Vivek and Reddy, VK and Reddy, V and Dowlatshahi, D and Dowlatshahi, Dar and Sourour, Nader and Sourour, Nader-Antoine and Oppenheim, Catherine and Mitha, AP and Mitha, Alim P and Davis, T and Davis, Stephen M and Weimar, Christian and Weimar, C and van Oostenbrugge, Robert J and Cobo, E and Cobo, Erik and Kleinig, Timothy J and Donnan, Geoffrey A and van der Lugt, Aad and Demchuk, Andrew M and Demchuk, AM and Berkhemer, Olvert A and Boers, Anna M M and Boers, Merel and Ford, Ian and Ford, Gary A and Ford, Gary and Muir, Keith W and Brown, B and Brown, B Scott and Brown, Martin M and Jovin, Tudor and Jovin, Tudor G and Jovin, TG and van Zwam, Wim H and Mitchell, Peter J and Hill, Michael D and Hill, MD and White, Phil and White, Philip and Bracard, S and Bracard, Serge and Goyal, M and Goyal, Mayank and Fransen, Puck SS and Beumer, Debbie and ... and HERMES Collaborators and HERMES collaborators
The Lancet Neurology, ISSN 1474-4422, 10/2018, Volume 17, Issue 10, pp. 895 - 904
Journal Article